CAnadian Normoglycemia Outcomes Evaluation Study

Trial Profile

CAnadian Normoglycemia Outcomes Evaluation Study

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2012

At a glance

  • Drugs Rosiglitazone/metformin (Primary)
  • Indications Glucose intolerance; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms CANOE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 May 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top